Sarilumab treatment of hospitalised patients with severe or critical COVID-19: a multinational, randomised, adaptive, phase 3, double-blind, placebo-controlled trial

Francois-Xavier Lescure, Hitoshi Honda, Robert A. Fowler, Jennifer Sloane Lazar, Genming Shi, Peter Wung, Naimish Patel, Owen Hagino
doi: https://doi.org/10.1101/2021.02.01.21250769
Back to top
Posted February 03, 2021.
Download PDF

Supplementary Material

Data/Code
Email
Sarilumab treatment of hospitalised patients with severe or critical COVID-19: a multinational, randomised, adaptive, phase 3, double-blind, placebo-controlled trial
Francois-Xavier Lescure, Hitoshi Honda, Robert A. Fowler, Jennifer Sloane Lazar, Genming Shi, Peter Wung, Naimish Patel, Owen Hagino
medRxiv 2021.02.01.21250769; doi: https://doi.org/10.1101/2021.02.01.21250769
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area